What they were paid
Y-mAbs Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2024 | $95,000 | $41,975 | $125,817 | $0 | $262,792 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Y-mAbs Therapeutics, Inc. DEF 14A filed May 30, 2025, accession 0001558370-25-008299, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2024Y-mAbs Therapeutics pays directors a $50,000 cash retainer.
Committees
FY2024 · as the proxy prints themAudit
The rest of the Y-mAbs Therapeutics board
FY2024 · as the company reported each| Director | Role | FY2024 total |
|---|---|---|
| Ashutosh Tyagi | Independent Director | $227,792 |
| David N. Gill | Independent Director | $250,292 |
| Johan Wedell-Wedellsborg | Independent Director | $227,792 |
| Laura J. Hamill | Independent Director | $237,792 |
| Mary Tagliaferri | Independent Director | $602,497 |
| Michael Rossi | Director | $0 |
| Thomas Gad | Director | $0 |
The full Y-mAbs Therapeutics compensation record
free company briefThis page is one director within Y-mAbs Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat